United States Drug Enforcement Administration

WASHINGTON – The Drug Enforcement Administration announced today that it is increasing Aggregate Production Quotas available to pharmaceutical manufacturers for the production of controlled substance medications that are in high demand due to the coronavirus (COVID-19) pandemic. DEA will also approve increases in imports of medications necessary for patients on...

WASHINGTON – The upcoming National Prescription Drug Take Back Day scheduled for Saturday, April 25, 2020 is postponed due to the ongoing coronavirus (COVID-19) pandemic. DEA will reschedule Take Back Day for a date shortly after the health crisis recedes and national emergency guidelines are lifted. The health and safety...

WASHINGTON – Former president of Venezuela Nicolás Maduro Moros, Venezuela’s vice president for the economy, Venezuela’s minister of defense, and Venezuela’s chief supreme court justice are among those charged in New York City; Washington, D.C.; and Miami, along with current and former Venezuelan government officials and two Fuerzas Armadas Revolucionarias...

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...

WASHINGTON – During the unprecedented health emergency caused by the ongoing coronavirus (COVID-19) pandemic, the health and safety of our communities is DEA’s top priority. DEA is responding appropriately to ensure Americans continue to have access to necessary medications and controlled substances. DEA’s efforts include supporting prescribing practices that limit...

WASHINGTON – The Justice Department and the Drug Enforcement Administration today announced the results of Project Python, a DEA-led interagency operation encompassing all global investigations and related disruption activities targeting the Cártel de Jalisco Nueva Generación (CJNG). This announcement marks the successful conclusion of six months of investigative and enforcement...

SAN FRANCISCO – The Drug Enforcement Administration San Francisco Division urges its DEA-registered practitioners and members of the public to be cautious of telephone calls from criminals posing as DEA or other law enforcement personnel threatening arrest and prosecution for supposed violations of federal drug laws or involvement in drug-trafficking...

FRESNO, Calif. — A federal grand jury returned a two-count indictment today against Yunquan Jiang, 48, a Chinese national residing in Fresno, charging him with cultivating and possessing with intent to distribute over 1,000 marijuana plants inside his residence, U.S. Attorney McGregor W. Scott and Drug Enforcement Administration Special Agent...

SAN FRANCISCO – A federal grand jury indicted Timothy Mulligan for the unlawful distribution of opioids, including fentanyl, outside the scope of professional practice and health care fraud, announced United States Attorney David L. Anderson and Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux. According to the...

SAN FRANCISCO – Eight defendants were indicted on narcotics trafficking charges, announced United States Attorney David L. Anderson, Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux, and Homeland Security Investigations (HSI) Special Agent in Charge Tatum King. The defendants were arrested on November 6, 2019, and February...